NCT02388633View on ClinicalTrials.gov

Acute Microvascular Changes With LDL Apheresis

CompletedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

March 1, 2015

Primary Completion Date

July 1, 2018

Study Completion Date

July 1, 2018

Conditions
Hyperlipidemia
Interventions
PROCEDURE

Plasmapharesis

Clinically-indicated LDL apheresis

Trial Locations (1)

97239

Oregon Health & Science University, Portland

All Listed Sponsors
lead

Oregon Health and Science University

OTHER

NCT02388633 - Acute Microvascular Changes With LDL Apheresis | Biotech Hunter | Biotech Hunter